Perfuze
PrivateLast Round
Series A
Extension
Mar 13, 2025
Total Funding Raised
$76.39M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Perfuze is a medical device company that develops catheter-based aspiration technology for the treatment of acute ischemic stroke.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Clinical Trials
Business Model
B2B
Customer Profile
Hardware Sales
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Perfuze Comparables
Compare Perfuze with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Anaconda Biomed S.L. | 92% | |
| MIVI Neuroscience | 89% | |
| RapidPulse | 89% | |
Perfuze Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Mar 13, 2025 | ||||
| Series A Extension | Mar 13, 2024 | ||||
| Series A | Feb 9, 2022 | ||||
| Seed | Jan 29, 2019 |
Key People
Founding team and executive leadership
Perfuze Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| EQT Life Sciences | Series A Extension, Series A |
| SV Health Investors | Series A Extension, Series A |
| Seroba Life Sciences | Series A Extension, Series A |
| Earlybird Venture Capital | Series A Extension, Series A, Seed |
| Enterprise Ireland | Seed, Series A |
| HBM Partners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 20, 2026
Monthly visitors increased 32% MoM.
- Mar 17, 2026
Received clearance for device in super-bore aspiration market.
Perfuze Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Perfuze's valuation, stock price, and market status.